MedPage Today illustration |
Kentucky Health News
One of the many challenges facing Kentuckians who remain unvaccinated against the coronavirus is that they still have unanswered questions about vaccines, some based on facts and others based on myths. This story is an attempt to sort through some of those questions and to counter misinformation.
This information is not only for the unvaccinated. Kentucky Health News encourages individuals who have already been vaccinated to use it as a resource when talking to their loved ones about getting vaccinated, since friends and family have proven to be highly influential in persuading them to do so.
Covid-19 is no worse than the seasonal flu, right? Wrong. While influenza and Covid-19 are both contagious respiratory illnesses, they are caused by different viruses. Covid-19 appears to be more contagious and to spread more quickly, and is more deadly. Preliminary estimates from the Centers for Disease Control and Prevention are that the U.S. had 35 million flu cases and 20,000 deaths from it in the 2019-20 flu season, for a death rate of 0.06 percent. The U.S. has had more than 79 million confirmed cases of the coronavirus and over 977,000 deaths from Covid-19. In Kentucky, there have been over 1 million cases and more than 14,000 deaths.
Kids don't get it, do they? Yes, they do. Children can be infected with the virus, and can get sick from Covid-19 and spread the virus to others without knowing they have it. In Kentucky, more than one-fifth of cases have been in people under 20. Most children have mild symptoms or no symptoms, but some have become severely ill from the disease and some have died. They can also get a rare but serious condition, Multisystem Inflammatory Syndrome, that sometimes doesn't show up until weeks after the infection. Kentucky has had more than 100 reported cases, according to the CDC. The more contagious Omicron variant of the virus that recently became dominant seems to affect them more.
Chart from University of Kentucky College of Medicine; for a larger version, click on it. |
In July, the Food and Drug Administration added a new warning about the J & J vaccine because it was linked to a rare neurological condition, Guillain-BarrĂ© syndrome. Preliminary research reported in July found 100 Americans out of more than 12 million who had developed the syndrome after receiving the vaccine; one died and 95 were hospitalized. The FDA said in a news release that “the known and potential benefits” of the vaccine “clearly outweigh the known and potential risks.” Through March 24, there have been around 310 preliminary reports of Guillain-Barre syndrome out of more than 18.5 million J&J vaccine doses administered, according to the CDC. These cases have largely been reported about two weeks after vaccination and mostly in men, many 50 years and older.
Serious adverse reactions after a coronavirus vaccination are rare, says the CDC. Anaphylaxis, which can occur after any vaccination, is severe and has occurred in approximately five people per million vaccinated in the U.S. Clinics keep people 15 minutes after a shot to make sure they don't have a reaction.
As of March 24, there have been 2,323 preliminary reports of myocarditis and pericarditis among people 30 and younger who received a coronavirus vaccine. Most cases have followed the Pfizer or Moderna vaccine, particularly in male teenagers and young adults. The CDC has confirmed 1,396 of the preliminary cases.
A recent study, published in JAMA Network, found that "passive surveillance" reporting in the U.S. showed an increased risk of myocarditis after receiving either Pfizer or Moderna Covid-19 vaccine, the mRNA-based vaccines. The risk was highest after the second vaccine dose in adolescent males and young men under the age of 25. The heart condition is treatable.
The study notes that among more than 192 million persons older than 12 receiving more than 354 million mRNA-based Covid-19 vaccines during the study period, there were 1,991 reports of myocarditis, with 1,626 of them meeting the case definition of the disease.
"Among persons younger than 30 years of age, there were no confirmed cases of myocarditis in those who died after mRNA-based Covid-19 vaccination without another identifiable cause and there was 1 probable case of myocarditis but there was insufficient information available for a thorough investigation," says the report.
The report concludes that while this is a "rare but serious adverse event" than can occur after taking these vaccines, "This risk should be considered in the context of the benefits of Covid-19 vaccination."
Do I need a shot if I've already had the virus? The CDC recommends that those who have been infected with the virus should be vaccinated, because we don't know how long or strong the resulting immunity is. "Emerging evidence shows that getting a Covid-19 vaccine after you recover from Covid-19 infection provides added protection to your immune system. One study showed that, for people who already had Covid-19, those who do not get vaccinated after their recovery are more than two times as likely to get Covid-19 again than those who get fully vaccinated," says the CDC. If you were treated for Covid-19 with monoclonal antibodies or convalescent plasma, wait 90 days before getting a vaccine.
I got fully immunized, but then got infected. How did that happen? No vaccine is 100% effective, health officials say. The Pfizer and Moderna vaccines are about 95% effective in preventing Covid-19 in those without prior infections. The Johnson & Johnson vaccine has a 72% overall efficacy rate and an 86% efficacy against severe disease in the U.S.
What's the latest information on who needs a booster? Research has found that a booster shot of the Pfizer-BioNTech or Moderna vaccine is needed to protect against the highly contagious Omicron variant of the virus.
However, a CDC study published Feb. 11 found that booster shots of the Pfizer-BioNTech and Moderna vaccines are highly effective against moderate and severe Covid-19 for about two months after a third dose, but lose substantial effectiveness after about four months, suggesting the need for additional boosters.
The study found the vaccine was 91% effective in preventing hospitalization during the two months after getting the shot, but fell to 78% effective after four months. Vaccine effectiveness against Covid-19 associated emergency department or urgent care visits also dropped over time, falling from 87% in the first two months to 66% after four months. After more than five months, vaccine effectiveness fell to roughly 31%, although the researchers note that there was little data available for this group of people
Adults 18 years and older can get any of the Covid-19 vaccines as a booster. A booster is recommended five months after the second shot for those who initially received a Pfizer-BioNTech or Moderna vaccine.
The CDC recommends 12-to-17-year-olds should get the Pfizer booster at least five months after their second Pfizer shot.
Additionally, the CDC recommends that moderately or severely immunocompromised 5-11-year-olds receive a booster dose of vaccine 28 days after their second shot.
Everyone who received the Johnson & Johnson (Janssen) vaccine is eligible for a booster shot at least two months after they get the single-dose vaccine. It is especially important for those who got the J&J vaccine to get a booster, since it has been shown to be less effective over time compared to the Pfizer and Moderna vaccines. The CDC recommends encourages those who got the J&J vaccine to get a Moderna or Pfizer booster in most situations.
The latest guidance says people can receive a different brand of vaccine as a booster than they did their initial shots.
Who needs a 3rd booster shot? The CDC recommends that certain immunocompromised individuals and people over the age of 50 who received their first Moderna or Pfizer Covid-19 booster shot at least four months ago to get another booster of either vaccine.
CDC also recommends that adults who have received a one-dose J&J Covid-19 vaccine and a J&J booster at least four months ago may now receive a second Covid-19 booster of either the Moderna or Pfizer vaccine.
This recommendation comes after the U.S. Food and Drug Administration authorized the second booster on March 29.
"These updated recommendations acknowledge the increased risk of severe disease in certain populations including those who are elderly or over the age of 50 with multiple underlying conditions, along with the currently available data on vaccine and booster effectiveness," the agency said in a statement about the new recommendations.
Children and Covid-19 vaccinations: Most children and all teens can get a Covid-19 vaccination.
The Pfizer-BioNTech Covid-19 vaccine is approved for children 12 and older in the same dosage as adults, which comes in a purple capped vial.
The Pfizer-BioNTech Covid-19 vaccine for children 5 to 11 is one-third of the adult dose and comes in an orange capped vial and is delivered with a smaller needle, designed specifically for children.
Both of these vaccines require two doses, given three weeks apart.
Why do I need to wear a mask if I've been vaccinated? Research indicates that vaccinated people who contract the highly contagious Omicron variant can spread it to others. The CDC advises universal masking for everyone indoors, regardless of vaccination status. Several studies show that properly wearing masks slows the spread of the virus, as part of a multi-layered prevention approach.
The largest randomized controlled study of masks, led by researchers from Stanford and Yale universities, looked at the benefits of surgical-mask use by more than 342,000 adults in Bangladesh. It found that mask usage increased 29 percent in the intervention group where masks were promoted, and the group showed an 11% reduction in Covid-19 infections, with a 35% reduction among those over 60. The Washington Post reports that the study is under peer review with the journal Science.Why are we hearing so much about the Omicron variant? It is now by far the dominant strain in the U.S. and Kentucky, and may be as contagious as measles, the most contagious virus known.
Chart from UK College of Public Health; click it to enlarge. |
Kentucky Health News is an independent news service of the Institute for Rural Journalism and Community Issues, based in the School of Journalism and Media at the University of Kentucky, with support from the Foundation for a Healthy Kentucky.
No comments:
Post a Comment